Globe Life Inc. (NYSE:GL) CEO James Matthew Darden Sells 24,890 Shares

Globe Life Inc. (NYSE:GL - Get Free Report) CEO James Matthew Darden sold 24,890 shares of the firm's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the completion of the transaction, the chief executive officer now directly owns 38,973 shares in the company, valued at $4,735,998.96. This trade represents a 38.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Globe Life Trading Down 1.4 %

Globe Life stock traded down $1.74 during trading on Friday, hitting $121.80. The company had a trading volume of 526,009 shares, compared to its average volume of 510,240. The company's 50 day simple moving average is $114.66 and its 200-day simple moving average is $108.08. The stock has a market cap of $10.22 billion, a price-to-earnings ratio of 10.19 and a beta of 0.81. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. As a group, analysts expect that Globe Life Inc. will post 13.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Versant Capital Management Inc grew its stake in shares of Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company's stock worth $27,000 after purchasing an additional 194 shares during the last quarter. Rakuten Securities Inc. bought a new position in Globe Life during the fourth quarter worth $28,000. Albion Financial Group UT bought a new stake in Globe Life in the 4th quarter valued at $28,000. Riverview Trust Co bought a new stake in Globe Life in the 3rd quarter valued at $32,000. Finally, Avalon Trust Co acquired a new stake in shares of Globe Life during the 4th quarter worth about $41,000. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

GL has been the subject of a number of research analyst reports. BMO Capital Markets started coverage on shares of Globe Life in a research report on Thursday, January 23rd. They set a "market perform" rating and a $114.00 price objective for the company. Morgan Stanley increased their price target on Globe Life from $123.00 to $125.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 11th. Keefe, Bruyette & Woods increased their price target on Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research report on Wednesday. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and increased their price target for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, Jefferies Financial Group lifted their price target on Globe Life from $107.00 to $114.00 and gave the company a "hold" rating in a research report on Tuesday, December 10th. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $133.10.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.